131 related articles for article (PubMed ID: 37916667)
21. Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liver.
Zhang Y; Sato R; Fukami T; Nakano M; Nakajima M
Xenobiotica; 2021 Dec; 51(12):1352-1359. PubMed ID: 34779706
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
Nielsen LM; Holm NB; Leth-Petersen S; Kristensen JL; Olsen L; Linnet K
Drug Test Anal; 2017 May; 9(5):671-679. PubMed ID: 27400739
[TBL] [Abstract][Full Text] [Related]
23. Human liver enzymes responsible for metabolic elimination of tyramine; a vasopressor agent from daily food.
Niwa T; Murayama N; Umeyama H; Shimizu M; Yamazaki H
Drug Metab Lett; 2011 Aug; 5(3):216-9. PubMed ID: 21679153
[TBL] [Abstract][Full Text] [Related]
24. Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro-In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound.
T'jollyn H; Snoeys J; Van Bocxlaer J; De Bock L; Annaert P; Van Peer A; Allegaert K; Mannens G; Vermeulen A; Boussery K
Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):537-543. PubMed ID: 27317395
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and clinical pharmacokinetics of 2-methyl-n-(2'-(pyrrolidinyl-1-ylsulfonyl)-n-[1,1'-biphenyl]-4-yl)propran-1-amine: insights into monoamine oxidase- and CYP-mediated disposition by integration of in vitro ADME tools.
Sawant Basak A; Byon W; Tseng-Lovering E; Funk C; Wood L; Lin C; Delnomdedieu M; Verhoest P; Parikh V; Cox LM; Miller E; Gao H; Obach RS
Xenobiotica; 2014 May; 44(5):438-54. PubMed ID: 24304147
[TBL] [Abstract][Full Text] [Related]
26. Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin.
Haritos VS; Ghabrial H; Ahokas JT; Ching MS
Pharmacogenetics; 2000 Oct; 10(7):591-603. PubMed ID: 11037801
[TBL] [Abstract][Full Text] [Related]
27. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.
Desta Z; Wu GM; Morocho AM; Flockhart DA
Drug Metab Dispos; 2002 Mar; 30(3):336-43. PubMed ID: 11854155
[TBL] [Abstract][Full Text] [Related]
28. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
[TBL] [Abstract][Full Text] [Related]
29. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
[TBL] [Abstract][Full Text] [Related]
30. In-vitro cytochrome P450 dependent metabolism of oxybutynin to N-deethyloxybutynin in humans.
Yaïch M; Popon M; Médard Y; Aigrain EJ
Pharmacogenetics; 1998 Oct; 8(5):449-51. PubMed ID: 9825837
[TBL] [Abstract][Full Text] [Related]
31. A pilot study of cerebral metabolism and serotonin 5-HT
Egger K; Gudmundsen F; Jessen NS; Baun C; Poetzsch SN; Shalgunov V; Herth MM; Quednow BB; Martin-Soelch C; Dornbierer D; Scheidegger M; Cumming P; Palner M
Front Pharmacol; 2023; 14():1140656. PubMed ID: 37841918
[No Abstract] [Full Text] [Related]
32. Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.
Zhai W; Li L; Zhao J; Xiang P; Liu M; Shi Y; Dang Y
Drug Test Anal; 2022 Jul; 14(7):1300-1309. PubMed ID: 35312166
[TBL] [Abstract][Full Text] [Related]
33. Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.
Yasui-Furukori N; Hidestrand M; Spina E; Facciolá G; Scordo MG; Tybring G
Drug Metab Dispos; 2001 Oct; 29(10):1263-8. PubMed ID: 11560868
[TBL] [Abstract][Full Text] [Related]
34. Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT.
Barker SA
Psychopharmacology (Berl); 2022 Jun; 239(6):1749-1763. PubMed ID: 35064294
[TBL] [Abstract][Full Text] [Related]
35. High-throughput screening to estimate single or multiple enzymes involved in drug metabolism: microtitre plate assay using a combination of recombinant CYP2D6 and human liver microsomes.
Yamamoto T; Suzuki A; Kohno Y
Xenobiotica; 2003 Aug; 33(8):823-39. PubMed ID: 12936703
[TBL] [Abstract][Full Text] [Related]
36. Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.
Natsui K; Mizuno Y; Tani N; Yabuki M; Komuro S
Eur J Drug Metab Pharmacokinet; 2007; 32(3):131-7. PubMed ID: 18062405
[TBL] [Abstract][Full Text] [Related]
37. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Mäenpää J; Pelkonen O
Drug Metab Dispos; 2007 Jul; 35(7):1135-41. PubMed ID: 17431033
[TBL] [Abstract][Full Text] [Related]
38. Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.
Natsui K; Mizuno Y; Tani N; Yabuki M; Komuro S
Eur J Drug Metab Pharmacokinet; 2007; 32(4):233-40. PubMed ID: 18348473
[TBL] [Abstract][Full Text] [Related]
39. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of dexfenfluramine in human liver microsomes and by recombinant enzymes: role of CYP2D6 and 1A2.
Haritos VS; Ching MS; Ghabrial H; Gross AS; Taavitsainen P; Pelkonen O; Battaglia SE; Smallwood RA; Ahokas JT
Pharmacogenetics; 1998 Oct; 8(5):423-32. PubMed ID: 9825834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]